APOE and Alzheimer disease: Delineation of the role of genetics in the diagnosis and risk prediction in late-onset AD is complicated since up to 75% of APOE4 carriers do not develop AD and up to 50% of individuals with AD are APOE4 noncarriers [39, 40].